Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Darryl Falzarano

Showing results (61-70 of 99) with videos related to

Pageof 10
Sort By:
Antiviral Research|April 9, 2017
Efficacy of antibody-based therapies against Middle East respiratory syndrome coronavirus (MERS-CoV) in common marmosetsNeeltje van Doremalen, Darryl Falzarano, Tianlei Ying, et al.
Nature Medicine|September 10, 2013
Treatment with interferon-α2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaquesDarryl Falzarano, Emmie de Wit, Angela L Rasmussen, et al.
Vaccines|April 27, 2026
Engineering a Modular PapMV Nanoparticle Vaccine: Comparative Efficacy of a Covalent and a Non-Covalent N-Antigen Vaccine Against Emerging SARS-CoV-2 VariantsLéa-J Blanchette, Marilène Bolduc, Tekeleselassie Woldemariam, et al.
Journal of Virology|November 5, 2024
Studying bats using a One Health lens: bridging the gap between bat virology and disease ecologyVictoria Gonzalez, Arianna M Hurtado-Monzón, Sabrina O'Krafka, et al.
Biorxiv : the Preprint Server for Biology|January 20, 2021
Male sex and age biases viral burden, viral shedding, and type 1 and 2 interferon responses during SARS-CoV-2 infection in ferretsMagen E Francis, Brian Richardson, Mara McNeil, et al.
Nature Communications|July 2, 2025
Bat-specific adaptations in interferon signaling and GBP1 contribute to enhanced antiviral capacityVictoria Gonzalez, Briallen Lobb, Jacob Côté, et al.
Journal of Infection in Developing Countries|February 24, 2020
2019-nCoV (Wuhan virus), a novel Coronavirus: human-to-human transmission, travel-related cases, and vaccine readinessRobyn Ralph, Jocelyne Lew, Tiansheng Zeng, et al.
Antimicrobial Agents and Chemotherapy|January 26, 2023
N-Phenylpyridine-3-Carboxamide and 6-Acetyl-1H-Indazole Inhibit the RNA Replication Step of the Dengue Virus Life CycleAïssatou Aïcha Sow, Felix Pahmeier, Yann Ayotte, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 25, 2013
Middle East respiratory syndrome coronavirus (MERS-CoV) causes transient lower respiratory tract infection in rhesus macaquesEmmie de Wit, Angela L Rasmussen, Darryl Falzarano, et al.
Iscience|October 9, 2023
Third COVID-19 vaccine dose boosts antibody function in Rwandans with high HIV viral loadCynthia L Swan, Valentine Dushimiyimana, Pacifique Ndishimye, et al.
Pageof 10

Showing results (61-70 of 99) with videos related to

Sort By:
Pageof 10
Antiviral Research|April 9, 2017
Efficacy of antibody-based therapies against Middle East respiratory syndrome coronavirus (MERS-CoV) in common marmosetsNeeltje van Doremalen, Darryl Falzarano, Tianlei Ying, et al.
Nature Medicine|September 10, 2013
Treatment with interferon-α2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaquesDarryl Falzarano, Emmie de Wit, Angela L Rasmussen, et al.
Vaccines|April 27, 2026
Engineering a Modular PapMV Nanoparticle Vaccine: Comparative Efficacy of a Covalent and a Non-Covalent N-Antigen Vaccine Against Emerging SARS-CoV-2 VariantsLéa-J Blanchette, Marilène Bolduc, Tekeleselassie Woldemariam, et al.
Journal of Virology|November 5, 2024
Studying bats using a One Health lens: bridging the gap between bat virology and disease ecologyVictoria Gonzalez, Arianna M Hurtado-Monzón, Sabrina O'Krafka, et al.
Biorxiv : the Preprint Server for Biology|January 20, 2021
Male sex and age biases viral burden, viral shedding, and type 1 and 2 interferon responses during SARS-CoV-2 infection in ferretsMagen E Francis, Brian Richardson, Mara McNeil, et al.
Nature Communications|July 2, 2025
Bat-specific adaptations in interferon signaling and GBP1 contribute to enhanced antiviral capacityVictoria Gonzalez, Briallen Lobb, Jacob Côté, et al.
Journal of Infection in Developing Countries|February 24, 2020
2019-nCoV (Wuhan virus), a novel Coronavirus: human-to-human transmission, travel-related cases, and vaccine readinessRobyn Ralph, Jocelyne Lew, Tiansheng Zeng, et al.
Antimicrobial Agents and Chemotherapy|January 26, 2023
N-Phenylpyridine-3-Carboxamide and 6-Acetyl-1H-Indazole Inhibit the RNA Replication Step of the Dengue Virus Life CycleAïssatou Aïcha Sow, Felix Pahmeier, Yann Ayotte, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 25, 2013
Middle East respiratory syndrome coronavirus (MERS-CoV) causes transient lower respiratory tract infection in rhesus macaquesEmmie de Wit, Angela L Rasmussen, Darryl Falzarano, et al.
Iscience|October 9, 2023
Third COVID-19 vaccine dose boosts antibody function in Rwandans with high HIV viral loadCynthia L Swan, Valentine Dushimiyimana, Pacifique Ndishimye, et al.
Pageof 10